Loading…
ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY
Saved in:
| Published in: | Hematological oncology 2021-06, Vol.39 (S2) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c1430-b0366224fee5850fadec5ba46b107ee114fe320240d120fe1e95f20a58154b383 |
|---|---|
| cites | |
| container_end_page | |
| container_issue | S2 |
| container_start_page | |
| container_title | Hematological oncology |
| container_volume | 39 |
| creator | Wang, M. Rule, S. Zinzani, P. L. Goy, A. Casasnovas, O. Smith, S. D. Damaj, G. Doorduijn, J. K. Lamy, T. Morschhauser, F. Panizo, C. Shah, B. Davies, A. Eek, R. Dupuis, J. Jacobsen, E. Kater, A. P. Le Gouill, S. Oberic, L. Robak, T. Jain, P. Calvo, R. Tao, L. Dlugosz‐Danecka, M. |
| description | |
| doi_str_mv | 10.1002/hon.58_2880 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2541701816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2541701816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1430-b0366224fee5850fadec5ba46b107ee114fe320240d120fe1e95f20a58154b383</originalsourceid><addsrcrecordid>eNotkMtOwzAQRS0EEqWw4gcssURpx86jDjs3dUgk56HEEcrKSlpHUEEDCRXi7wlqV7O4586MDkL3BBYEgC5f-8PCZZoyBhdoRsD3LQKef4lmQFfMAmrTa3QzjnuAKQM2Qz884JKvi0rFabzGSZZmKhIFz2scpzjnKhapKvFLrCJcCMnzUmyWhQgLHqisqHHCUyUFDoSUWNZJHmUJf8JhnHI58WUlp3JYZAnmOI94KTDFpao29S266pr30dyd5xxVoVBBZMnsOZ5esrbEscFqwfY8Sp3OGJe50DU7s3XbxvFaAitjCJkSmwJ1YEcodIYY3-0oNC4jrtPazJ6jh9Pez6H_OprxW-_743CYTmrqOmQFhBFvoh5P1Hbox3Ewnf4c3j6a4VcT0P9m9WRWn83af5X9YR0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2541701816</pqid></control><display><type>article</type><title>ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Wang, M. ; Rule, S. ; Zinzani, P. L. ; Goy, A. ; Casasnovas, O. ; Smith, S. D. ; Damaj, G. ; Doorduijn, J. K. ; Lamy, T. ; Morschhauser, F. ; Panizo, C. ; Shah, B. ; Davies, A. ; Eek, R. ; Dupuis, J. ; Jacobsen, E. ; Kater, A. P. ; Le Gouill, S. ; Oberic, L. ; Robak, T. ; Jain, P. ; Calvo, R. ; Tao, L. ; Dlugosz‐Danecka, M.</creator><creatorcontrib>Wang, M. ; Rule, S. ; Zinzani, P. L. ; Goy, A. ; Casasnovas, O. ; Smith, S. D. ; Damaj, G. ; Doorduijn, J. K. ; Lamy, T. ; Morschhauser, F. ; Panizo, C. ; Shah, B. ; Davies, A. ; Eek, R. ; Dupuis, J. ; Jacobsen, E. ; Kater, A. P. ; Le Gouill, S. ; Oberic, L. ; Robak, T. ; Jain, P. ; Calvo, R. ; Tao, L. ; Dlugosz‐Danecka, M.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.58_2880</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphoma ; Mantle cell lymphoma</subject><ispartof>Hematological oncology, 2021-06, Vol.39 (S2)</ispartof><rights>2021 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1430-b0366224fee5850fadec5ba46b107ee114fe320240d120fe1e95f20a58154b383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Wang, M.</creatorcontrib><creatorcontrib>Rule, S.</creatorcontrib><creatorcontrib>Zinzani, P. L.</creatorcontrib><creatorcontrib>Goy, A.</creatorcontrib><creatorcontrib>Casasnovas, O.</creatorcontrib><creatorcontrib>Smith, S. D.</creatorcontrib><creatorcontrib>Damaj, G.</creatorcontrib><creatorcontrib>Doorduijn, J. K.</creatorcontrib><creatorcontrib>Lamy, T.</creatorcontrib><creatorcontrib>Morschhauser, F.</creatorcontrib><creatorcontrib>Panizo, C.</creatorcontrib><creatorcontrib>Shah, B.</creatorcontrib><creatorcontrib>Davies, A.</creatorcontrib><creatorcontrib>Eek, R.</creatorcontrib><creatorcontrib>Dupuis, J.</creatorcontrib><creatorcontrib>Jacobsen, E.</creatorcontrib><creatorcontrib>Kater, A. P.</creatorcontrib><creatorcontrib>Le Gouill, S.</creatorcontrib><creatorcontrib>Oberic, L.</creatorcontrib><creatorcontrib>Robak, T.</creatorcontrib><creatorcontrib>Jain, P.</creatorcontrib><creatorcontrib>Calvo, R.</creatorcontrib><creatorcontrib>Tao, L.</creatorcontrib><creatorcontrib>Dlugosz‐Danecka, M.</creatorcontrib><title>ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY</title><title>Hematological oncology</title><subject>Lymphoma</subject><subject>Mantle cell lymphoma</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotkMtOwzAQRS0EEqWw4gcssURpx86jDjs3dUgk56HEEcrKSlpHUEEDCRXi7wlqV7O4586MDkL3BBYEgC5f-8PCZZoyBhdoRsD3LQKef4lmQFfMAmrTa3QzjnuAKQM2Qz884JKvi0rFabzGSZZmKhIFz2scpzjnKhapKvFLrCJcCMnzUmyWhQgLHqisqHHCUyUFDoSUWNZJHmUJf8JhnHI58WUlp3JYZAnmOI94KTDFpao29S266pr30dyd5xxVoVBBZMnsOZ5esrbEscFqwfY8Sp3OGJe50DU7s3XbxvFaAitjCJkSmwJ1YEcodIYY3-0oNC4jrtPazJ6jh9Pez6H_OprxW-_743CYTmrqOmQFhBFvoh5P1Hbox3Ewnf4c3j6a4VcT0P9m9WRWn83af5X9YR0</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Wang, M.</creator><creator>Rule, S.</creator><creator>Zinzani, P. L.</creator><creator>Goy, A.</creator><creator>Casasnovas, O.</creator><creator>Smith, S. D.</creator><creator>Damaj, G.</creator><creator>Doorduijn, J. K.</creator><creator>Lamy, T.</creator><creator>Morschhauser, F.</creator><creator>Panizo, C.</creator><creator>Shah, B.</creator><creator>Davies, A.</creator><creator>Eek, R.</creator><creator>Dupuis, J.</creator><creator>Jacobsen, E.</creator><creator>Kater, A. P.</creator><creator>Le Gouill, S.</creator><creator>Oberic, L.</creator><creator>Robak, T.</creator><creator>Jain, P.</creator><creator>Calvo, R.</creator><creator>Tao, L.</creator><creator>Dlugosz‐Danecka, M.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202106</creationdate><title>ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY</title><author>Wang, M. ; Rule, S. ; Zinzani, P. L. ; Goy, A. ; Casasnovas, O. ; Smith, S. D. ; Damaj, G. ; Doorduijn, J. K. ; Lamy, T. ; Morschhauser, F. ; Panizo, C. ; Shah, B. ; Davies, A. ; Eek, R. ; Dupuis, J. ; Jacobsen, E. ; Kater, A. P. ; Le Gouill, S. ; Oberic, L. ; Robak, T. ; Jain, P. ; Calvo, R. ; Tao, L. ; Dlugosz‐Danecka, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1430-b0366224fee5850fadec5ba46b107ee114fe320240d120fe1e95f20a58154b383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Lymphoma</topic><topic>Mantle cell lymphoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, M.</creatorcontrib><creatorcontrib>Rule, S.</creatorcontrib><creatorcontrib>Zinzani, P. L.</creatorcontrib><creatorcontrib>Goy, A.</creatorcontrib><creatorcontrib>Casasnovas, O.</creatorcontrib><creatorcontrib>Smith, S. D.</creatorcontrib><creatorcontrib>Damaj, G.</creatorcontrib><creatorcontrib>Doorduijn, J. K.</creatorcontrib><creatorcontrib>Lamy, T.</creatorcontrib><creatorcontrib>Morschhauser, F.</creatorcontrib><creatorcontrib>Panizo, C.</creatorcontrib><creatorcontrib>Shah, B.</creatorcontrib><creatorcontrib>Davies, A.</creatorcontrib><creatorcontrib>Eek, R.</creatorcontrib><creatorcontrib>Dupuis, J.</creatorcontrib><creatorcontrib>Jacobsen, E.</creatorcontrib><creatorcontrib>Kater, A. P.</creatorcontrib><creatorcontrib>Le Gouill, S.</creatorcontrib><creatorcontrib>Oberic, L.</creatorcontrib><creatorcontrib>Robak, T.</creatorcontrib><creatorcontrib>Jain, P.</creatorcontrib><creatorcontrib>Calvo, R.</creatorcontrib><creatorcontrib>Tao, L.</creatorcontrib><creatorcontrib>Dlugosz‐Danecka, M.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, M.</au><au>Rule, S.</au><au>Zinzani, P. L.</au><au>Goy, A.</au><au>Casasnovas, O.</au><au>Smith, S. D.</au><au>Damaj, G.</au><au>Doorduijn, J. K.</au><au>Lamy, T.</au><au>Morschhauser, F.</au><au>Panizo, C.</au><au>Shah, B.</au><au>Davies, A.</au><au>Eek, R.</au><au>Dupuis, J.</au><au>Jacobsen, E.</au><au>Kater, A. P.</au><au>Le Gouill, S.</au><au>Oberic, L.</au><au>Robak, T.</au><au>Jain, P.</au><au>Calvo, R.</au><au>Tao, L.</au><au>Dlugosz‐Danecka, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY</atitle><jtitle>Hematological oncology</jtitle><date>2021-06</date><risdate>2021</risdate><volume>39</volume><issue>S2</issue><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.58_2880</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2021-06, Vol.39 (S2) |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_2541701816 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Lymphoma Mantle cell lymphoma |
| title | ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A38%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ACALABRUTINIB%20MONOTHERAPY%20IN%20PATIENTS%20WITH%20RELAPSED/REFRACTORY%20MANTLE%20CELL%20LYMPHOMA:%20FINAL%20RESULTS%20FROM%20A%20PHASE%202%20STUDY&rft.jtitle=Hematological%20oncology&rft.au=Wang,%20M.&rft.date=2021-06&rft.volume=39&rft.issue=S2&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.58_2880&rft_dat=%3Cproquest_cross%3E2541701816%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1430-b0366224fee5850fadec5ba46b107ee114fe320240d120fe1e95f20a58154b383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2541701816&rft_id=info:pmid/&rfr_iscdi=true |